25 results on '"Center, Kimberly J."'
Search Results
2. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial
3. 1728. Immune Responses to Cross-Reactive Serotypes 6C and 15C After 20-Valent Pneumococcal Conjugate Vaccine in Infants
4. 1944. Tolerability and Safety of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Infants and Older Children in Global Studies
5. National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States
6. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial
7. A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations
8. 91. Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization
9. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children
10. Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants
11. Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy
12. Prevenar™ vaccination: Review of the global data, 2006
13. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use
14. Streptococcus pneumoniae: Description of the Pathogen, Disease Epidemiology, Treatment, and Prevention
15. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
16. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study
17. 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Preterm Versus Term Infants
18. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniaein healthy young children: a prospective observational study
19. Challenges in Estimating Efficacy Against Pneumococcal Pneumonia in Children
20. Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar®) since vaccine introduction
21. LACK OF ASSOCIATION OF KAWASAKI DISEASE AFTER IMMUNIZATION IN A COHORT OF INFANTS FOLLOWED FOR MULTIPLE AUTOIMMUNE DIAGNOSES IN A LARGE, PHASE-4 OBSERVATIONAL DATABASE SAFETY STUDY OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
22. Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era.
23. Decreased Vancomycin Susceptibility of Coagulase-Negative Staphylococci in a Neonatal Intensive Care Unit: Evidence of Spread of Staphylococcus warneri
24. Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar®) since vaccine introduction
25. letters.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.